Robinson Pharma, Inc.

Santa Ana, California

Classification

Private

Financials

Revenue & Profit

Revenue

Valuation

Valuation

Ratios

Revenue / EBITDA
$123 MM
Valuation / Revenue
$123 MM
Valuation / Employees
$123 MM
EBITDA / Revenue
$123 MM
1-Year CAGR (Revenue)
03
3-Year CAGR (Revenue)
11
1-Year CAGR (Employees)
19
3-Year CAGR (Employees)
96

People

Employee Figures

Employees

Key Executives

NameTitleSocialsEmailPhone
John DoeEmployee
--
Jane DoeEmployee
John DoeEmployee
John DoeEmployee

401K

Total Active Participants
1234
No. Participants with Account Balances
56789
Total Liabilities Start of Year
1234
Total Assets Start of Year
56789

Deals

M&A2024-03-15Completed

Seller

Founders Group

Investor Sponsors

NorthBridge PE

Deal Amount

$120M

Target Company Valuation

$1.20 MM

Techniques

Acquisition of Assets, Taken Private

Stake Tags

100%

Is PE deal

Yes

Is deal PE backed

Yes

Total Acquired

100%

Secondary Transaction2023-09-01Canceled

Target

BrightHealth Technologies

Seller

Early Investors Consortium

Investor Sponsors

--

Deal Amount

Undisclosed

Target Company Valuation

NaN

Techniques

Secondary Sale, Management Buy-out (MBO)

Stake Tags

Majority

Is PE deal

No

Is deal PE backed

Yes

Total Acquired

65%

Funding

About

About

Robinson Pharma, Inc. is a contract manufacturer specializing in the production of dietary supplements and personal health care products. The company was founded in 1989 by Tuong Nguyen, who established it with a focus on providing high-quality manufacturing services for nutritional supplements. Headquartered in Santa Ana, California, Robinson Pharma operates multiple facilities in the area, positioning itself as a key player in the U.S. supplement manufacturing market. With over three decades of experience, the company has grown to emphasize large-scale production capabilities and compliance with industry standards, serving a global client base. Business/Product Breakdown: Robinson Pharma, Inc. offers a comprehensive range of contract manufacturing services tailored to the dietary supplement and personal health care industries. Its product portfolio includes softgels, tablets, capsules, gummies, powders, and liquid supplements, with a particular emphasis on softgel production, where it claims the largest capacity in the United States. The company provides end-to-end solutions, encompassing custom formulation, private labeling, packaging, and shipping, allowing clients to outsource the entire production process. Robinson Pharma sources raw materials globally while ensuring all manufacturing occurs in the U.S., adhering to multiple third-party certifications for Good Manufacturing Practices (GMP), such as those from NSF, NPA, and USP. Its offerings extend to specialized products like vegetarian softgels, amino acids, herbal supplements, heart health supplements, and pet supplements, catering to diverse market needs. Additionally, the company produces its own branded lines, including U.S. Doctors' Clinical and Healthy America, alongside its contract manufacturing services. Robinson Pharma emphasizes short lead times and integrated solutions, positioning itself as a one-stop shop for clients seeking efficient production and distribution.

Keywords

Keywords

Classified

Private